Allergy/Immunology · Suffern, NY
NPI
1174526016
Since 2005
Specialty
Allergy/Immunology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
222 Route 59, Ste 109
Suffern, NY, 10901
Phone (845) 357-7277
Groups this clinician bills Medicare through
Medicare paid, 2024
$565K
17,490 services
Medicare patients, 2024
290
Average age 74
Drug cost, 2024
$575K
460 prescriptions
Company payments, 2025
$15K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joel H Selter was code J2357 (injection, omalizumab, 5 mg), 8,700 times for 16 patients. In total Joel H Selter billed 17,490 services in 50 codes, and Medicare paid $565K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 8,700 | 16 | $29.86 | $260K |
| 95004 Test - Miscellaneous | Office | 2,842 | 54 | $3.41 | $9,691 |
| 95044 Test - Miscellaneous | Office | 877 | 12 | $4.72 | $4,142 |
| 95165 Treatment - Miscellaneous | Office | 702 | 42 | $12.17 | $8,547 |
| 95117 Treatment - Miscellaneous | Office | 598 | 45 | $10.71 | $6,403 |
| 96372 Injection Administration | Office | 474 | 28 | $12.52 | $5,933 |
| 95024 Test - Miscellaneous | Office | 417 | 35 | $7.50 | $3,130 |
| 99213 Office E&M - Established | Office | 383 | 201 | $78.26 | $30K |
| 99214 Office E&M - Established | Office | 200 | 115 | $105.04 | $21K |
| 95018 Test - Miscellaneous | Office | 178 | 11 | $18.34 | $3,264 |
| 95012 Pulmonary | Office | 85 | 64 | $17.00 | $1,445 |
| 94060 Pulmonary Function Testing | Office | 82 | 64 | $33.79 | $2,770 |
| 87426 Immunoassay | Office | 71 | 55 | $34.62 | $2,458 |
| 99204 Office E&M - New | Office | 70 | 70 | $131.73 | $9,221 |
| 36410 Vascular | Office | 57 | 50 | $15.60 | $889 |
By year: 2022 $531K for 15,269 services; 2023 $571K for 16,671 services; 2024 $565K for 17,490 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87426 Immunoassay | 71 | 55 | $34.62 | $2,458 |
Medicare prescription drug claims, 2024
In 2024, the drug Joel H Selter prescribed most often to Medicare patients was Fluticasone Propionate, with 72 prescriptions and refills. In total Joel H Selter wrote 460 Medicare prescriptions that cost $575K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 72 | 108 | 22 | $709 |
| Azelastine Hcl Generic | 41 | 74 | 15 | $892 |
| Levocetirizine Dihydrochloride Generic | 33 | 51 | Under 11 | $235 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 30 | 44 | 16 | $1,284 |
| Montelukast Sodium Generic | 25 | 39 | Under 11 | $146 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 19 | 25 | Under 11 | $2,002 |
| Epinephrine Generic | 17 | 17 | 12 | $3,405 |
| Mometasone Furoate Generic | 17 | 19 | Under 11 | $991 |
| Hyqvia Igg/Hyaluronidase,recombinant | 17 | 17 | Under 11 | $179K |
| Breo Ellipta Fluticasone/Vilanterol | 12 | 12 | Under 11 | $4,677 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 12 | 12 | Under 11 | $225K |
| Famotidine Generic | 11 | 11 | Under 11 | $77.71 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 11 | 19 | Under 11 | $1,285 |
Brand drugs: 147 claims; generic drugs: 313 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joel H Selter $15K ($15K in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $13K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 26 | $13K |
| Novartis Pharmaceuticals Corporation NVS | 17 | $253 |
| CSL Behring CSL.AX | 13 | $248 |
| BioCryst US Sales Co., LLC | 18 | $204 |
| GlaxoSmithKline, LLC. GSK | 11 | $157 |
| Ionis Pharmaceuticals, Inc. IONS | 11 | $145 |
| Incyte Corporation INCY | 1 | $140 |
| Amgen Inc. AMGN | 5 | $96.21 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 5 | $91.55 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $88.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.